Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Systemic and inhaled fluoroquinolones - Important safety information from Marketing Authorisation Holders as approved by the HPRA
Notice type:
3rd Party Publications
Date:
29/10/2020
Problem Or Issue:
Important Safety Information from Marketing Authorisation Holders on risk of heart valve regurgitation/incompetence associated with fluoroquinolones for systemic and inhalation use
Important Safety Information - Systemic and inhaled fluoroquinolones
« Back
Date Printed: 19/04/2024